Clinical Trial Update: NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate [Phase 4]

View source ↗

Summary

Phase 4 study evaluating methylphenidate in children with Neurofibromatosis Type 1 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Neurofibromatosis Type 1 | Phase 4 | Status: COMPLETED